Cellosaurus OnyCap-23 (CVCL_IQ34)
| Cell line name | OnyCap-23 |
|---|---|
| Synonyms | Onycap-23; ONYCAP-23; Onycap23; ONYCAP23; Ony-Cap 23 |
| Accession | CVCL_IQ34 |
| Resource Identification Initiative | To cite this cell line use: OnyCap-23 (RRID:CVCL_IQ34) |
| Comments | Group: Patented cell line. From: Onyvax, Ltd; London; United Kingdom. Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 00032801. Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen. Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pMK16). Caution: Was originally thought to arise from the ascitic fluid of a prostate carcinoma patient and described as such in patent application GB008032.5 from Jan. 4, 2000. Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428. Cell type: Epithelial cell of prostate; CL=CL_0002231. |
| Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) |
| Hierarchy | Parent: CVCL_4889 (PNT2-C2) |
| Sex of cell | Male |
| Age at sampling | 33Y |
| Category | Transformed cell line |
| Publications | Patent=US7303911 |
| Cross-references | |
| Encyclopedic resources | Wikidata; Q54936434 |
| Entry history | |
| Entry creation | 03-Mar-2017 |
| Last entry update | 14-Aug-2025 |
| Version number | 11 |